Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
T cell-specific loss of IRF1 results in defective CD8 T cell activation and antitumor immunity.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2026
Effectiveness of Mavrilimumab in Viral Infections Including SARS-CoV-2 Infection - A Brief Review.
Journal: Infection & chemotherapy
Published: September 15, 2020
Showing 1-3 of 3
Last Updated: 09/26/2026